Tsuji Masato, Kawasaki Takanori, Matsuda Takeru, Arai Tomio, Gojo Satoshi, Takeuchi Jun K
Division of Bio-informational Pharmacology, Medical Research Institute, Tokyo Medical Dental University, Tokyo, Japan.
Department of Biological Sciences, Graduate School of Science, The University of Tokyo, Tokyo, Japan.
PLoS One. 2017 Jul 13;12(7):e0177988. doi: 10.1371/journal.pone.0177988. eCollection 2017.
Sexual dimorphisms are well recognized in various cardiac diseases such as ischemic cardiomyopathy (ICM), hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). Thorough understanding of the underlying genetic programs is crucial to optimize treatment strategies specified for each gender. By performing meta-analysis and microarray analysis, we sought to comprehensively characterize the sexual dimorphisms in the healthy and diseased heart at the level of both mRNA and miRNA transcriptome.
Existing mRNA microarray data of both mouse and human heart were integrated, identifying dozens/ hundreds of sexually dimorphic genes in healthy heart, ICM, HCM, and DCM. These sexually dimorphic genes overrepresented gene ontologies (GOs) important for cardiac homeostasis. Further, microarray of miRNA, isolated from mouse sham left ventricle (LV) (n = 6 & n = 5 for male & female) and chronic MI LV (n = 19 & n = 19) and from human normal LV (n = 6 & n = 6) and ICM LV (n = 4 & n = 5), was conducted. This revealed that 13 mouse miRNAs are sexually dimorphic in MI and 6 in normal heart. In human, 3 miRNAs were sexually dimorphic in ICM and 15 in normal heart. These data revealed miRNA-mRNA networks that operate in a sexually-biased fashion.
mRNA and miRNA transcriptome of normal and disease heart show significant sex differences, which might impact the cardiac homeostasis. Together this study provides the first comprehensive picture of the genome-wide program underlying the heart sexual dimorphisms, laying the foundation for gender specific treatment strategies.
在各种心脏疾病中,如缺血性心肌病(ICM)、肥厚型心肌病(HCM)和扩张型心肌病(DCM),性别差异已得到充分认识。深入了解潜在的遗传程序对于优化针对每种性别的治疗策略至关重要。通过进行荟萃分析和微阵列分析,我们试图在mRNA和miRNA转录组水平上全面表征健康和患病心脏中的性别差异。
整合了现有的小鼠和人类心脏mRNA微阵列数据,在健康心脏、ICM、HCM和DCM中鉴定出数十个/数百个性别差异基因。这些性别差异基因在对心脏稳态重要的基因本体(GO)中占比过高。此外,对从小鼠假手术左心室(LV)(雄性和雌性分别为n = 6和n = 5)和慢性心肌梗死LV(n = 19和n = 19)以及人类正常LV(n = 6和n = 6)和ICM LV(n = 4和n = 5)中分离的miRNA进行了微阵列分析。这表明13种小鼠miRNA在心肌梗死中存在性别差异,6种在正常心脏中存在性别差异。在人类中,3种miRNA在ICM中存在性别差异,15种在正常心脏中存在性别差异。这些数据揭示了以性别偏向方式运作的miRNA-mRNA网络。
正常和患病心脏的mRNA和miRNA转录组显示出显著的性别差异,这可能会影响心脏稳态。这项研究共同提供了心脏性别差异背后全基因组程序的首张综合图谱,为针对性别的治疗策略奠定了基础。